Oscar Health Inc’s recently made public that its Former Officer ALESSANDREA QUANE acquired Company’s shares for reported $2.6 million on May 16 ’25. In the deal valued at $17.52 per share,148,280 shares were bought.
Then, Robinson Elbert O. Jr. sold 25,000 shares, generating $410,750 in total proceeds. Upon selling the shares at $16.43, the Director now owns 64,512 shares.
Before that, ALESSANDREA QUANE bought 300 shares. Oscar Health Inc shares valued at $5,252 were divested by the Former Officer at a price of $17.51 per share.
Wells Fargo downgraded its Oscar Health Inc [OSCR] rating to an Equal weight from a an Overweight in a research note published on March 13, 2025; the price target was decreased to $16 from $20. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early December with a ‘”an Underperform”‘ rating. BofA Securities also remained covering OSCR and has decreased its forecast on November 06, 2024 with a “an Underperform” recommendation from previously “Neutral” rating. UBS started covering the stock on October 07, 2024. It rated OSCR as “a Neutral”.
Price Performance Review of OSCR
On Friday, Oscar Health Inc [NYSE:OSCR] saw its stock jump 5.80% to $17.52. Over the last five days, the stock has gained 2.40%. Oscar Health Inc shares have risen nearly 30.36% since the year began. Nevertheless, the stocks have fallen -23.26% over the past one year. While a 52-week high of $23.79 was reached on 05/08/25, a 52-week low of $11.20 was recorded on 04/21/25. SMA at 50 days reached $13.67, while 200 days put it at $15.93.
Levels Of Support And Resistance For OSCR Stock
The 24-hour chart illustrates a support level at 16.71, which if violated will result in even more drops to 15.91. On the upside, there is a resistance level at 18.00. A further resistance level may holdings at 18.49. The Relative Strength Index (RSI) on the 14-day chart is 75.01, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.59, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.13%. Stochastics %K at 77.47% indicates the stock is a holding.
The most recent change occurred on June 26, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $25 price target.
